早产儿严重先天性心脏病的一年死亡率和主要新生儿疾病负担趋势
结果显示死亡相对风险每年下降10.6%,而主要新生儿疾病相对风险每年上升8.3%;胎龄28-32周患儿与无先心病同龄儿相比超额风险最高。
要点
- 严重先心病早产儿一年死亡风险每年下降10.6%,主要新生儿疾病风险每年上升8.3%。
- 与无先心病早产儿相比,胎龄28-32周者死亡或主要疾病的超额风险最高。
- 结果提示需对严重先心病早产儿提供专门聚焦的新生儿医疗照护。
核心结论
- 过去十年间,严重先心病早产儿的一年死亡率下降,而主要新生儿疾病发生率上升。
- 胎龄28-32周的严重先心病早产儿与无先心病同龄儿相比死亡或主要疾病超额风险最高。
研究设计与样本
- 基于人群的行政数据集队列研究,纳入2011-2017年加州出生、胎龄26-36周、患有严重先心病的活产早产儿1921例。
主要发现
- 严重先心病早产儿死亡相对风险每研究年下降10.6%(RR 0.89,95%CI 0.84-0.95)。
- 严重先心病早产儿主要新生儿疾病相对风险每研究年上升8.3%(RR 1.08,95%CI 1.02-1.15)。
- 与无先心病早产儿相比,调整后死亡风险差在胎龄32周最高(9.7%,95%CI 8.3%-11.2%)。
- 调整后主要新生儿疾病风险差在胎龄28周最高(21.9%,95%CI 17.0%-26.9%)。
- 调整后复合结局风险差在胎龄30周最高(26.7%,95%CI 23.3%-30.1%)。
关键数值与推荐
- 严重先心病早产儿死亡RR每年0.89(95%CI 0.84-0.95),主要新生儿疾病RR每年1.08(95%CI 1.02-1.15)。
- 与无先心病早产儿相比,死亡调整后风险差在32周为9.7%(95%CI 8.3%-11.2%)。
- 主要新生儿疾病调整后风险差在28周为21.9%(95%CI 17.0%-26.9%)。
- 复合结局调整后风险差在30周为26.7%(95%CI 23.3%-30.1%)。
临床怎么用
- 对严重先心病早产儿应提供专门聚焦的新生儿医疗照护,尤其关注胎龄28-32周患儿的死亡和主要疾病风险。
- 在临床随访中需同时关注死亡率下降趋势下主要新生儿疾病负担上升的问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the trends of 1-year mortality and neonatal morbidities in preterm infants with serious congenital heart disease (CHD). STUDY DESIGN: This cohort study used a population-based administrative dataset of all liveborn infants of 26-36 weeks gestational age with serious CHD born in California between 2011 and 2017. We assessed 1-year mortality and major neonatal morbidities (ie, retinopathy of prematurity, bronchopulmonary dysplasia, necrotizing enterocolitis, intraventricular hemorrhage grade >2, and periventricular leukomalacia) across the study period and compared these outcomes with those in infants without CHD. RESULTS: We identified 1921 preterm infants with serious CHD. The relative risk (RR) of death decreased by 10.6% for each year of the study period (RR, 0.89; 95% CI, 0.84-0.95), and the RR of major neonatal morbidity increased by 8.3% for each year (RR, 1.08; 95% CI, 1.02-1.15). Compared with preterm neonates without any CHD (n = 234 522), the adjusted risk difference (ARD) for mortality was highest at 32 weeks of gestational age (9.7%; 95% CI, 8.3%-11.2%), that for major neonatal morbidity was highest at 28 weeks (21.9%; 95% CI, 17.0%-26.9%), and that for the combined outcome was highest at 30 weeks (26.7%; 95% CI, 23.3%-30.1%). CONCLUSIONS: Mortality in preterm neonates with serious CHD decreased over the last decade, whereas major neonatal morbidities increased. Preterm infants with a gestational age of 28-32 weeks have the highest mortality or morbidity compared with their peers without CHD. These results support the need for specialized and focused medical neonatal care in preterm neonates with serious CHD.
引用
- Steurer MA, Baer RJ, Chambers CD, et al. Mortality and Major Neonatal Morbidity in Preterm Infants with Serious Congenital Heart Disease. J Pediatr. 2021. PMID: 34454949. doi:10.1016/j.jpeds.2021.08.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。